Paperpal Prime Logo

Bioorganic and Medicinal Chemistry Letters : Impact Factor & More

eISSN: 1464-3405pISSN: 0960-894X

Aims and Scope of Bioorganic and Medicinal Chemistry Letters

Bioorganic & Medicinal Chemistry Letters is a scientific journal focusing on the results of research on the molecular structure of biological organisms and the interaction of biological targets with chemical agents. It is published by Elsevier, which also publishes Bioorganic & Medicinal Chemistry for longer works. Less

Key Metrics

CiteScore
5
Impact Factor
< 5
SJR
Q3Biochemistry
SNIP
0.75
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Bioorganic and Medicinal Chemistry Letters

Bioorganic and Medicinal Chemistry Letters Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher PERGAMON-ELSEVIER SCIENCE LTD
Language English
Frequency Semi-monthly
General Details
LanguageEnglish
FrequencySemi-monthly
Publication Start Year1991
Publisher URLVisit website
View less

Planning to publish in Bioorganic and Medicinal Chemistry Letters ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Bioorganic and Medicinal Chemistry Letters

Design, synthesis, and biological evaluation of sphingosine kinase 2 inhibitors derived from K145.
  • 1 Sep 2026
  • Bioorganic & medicinal chemistry letters
Design and synthesis of [1,2,4]triazolo[3,4-b]thiadiazine-1,2,4-oxadiazoles as EGFR tyrosine kinase inhibitors.
  • 1 Sep 2026
  • Bioorganic & medicinal chemistry letters
Design, synthesis and antibacterial evaluation of novel unsaturated butenolide-fatty amine hybrids against multidrug-resistant pathogens.
  • 1 Sep 2026
  • Bioorganic & medicinal chemistry letters
New thiazole-biaryls as small molecule immunomodulators (SMIs) targeting PD-1/PD-L1 axis.
  • 1 Sep 2026
  • Bioorganic & medicinal chemistry letters
Synthesis and preliminary enzymatic evaluation of polyol-based 4-phenylbutyrate derivatives.
  • 1 Sep 2026
  • Bioorganic & medicinal chemistry letters
Biological evaluation of guanidines, bisguanidines, and their derivatives as anti-Trypanosoma cruzi agents.
  • 1 Sep 2026
  • Bioorganic & medicinal chemistry letters
Design, synthesis, and biological evaluation of sphingosine kinase 2 inhibitors derived from K145.
  • 1 Sep 2026
  • Bioorganic & medicinal chemistry letters
Design and synthesis of [1,2,4]triazolo[3,4-b]thiadiazine-1,2,4-oxadiazoles as EGFR tyrosine kinase inhibitors.
  • 1 Sep 2026
  • Bioorganic & medicinal chemistry letters
Design, synthesis and antibacterial evaluation of novel unsaturated butenolide-fatty amine hybrids against multidrug-resistant pathogens.
  • 1 Sep 2026
  • Bioorganic & medicinal chemistry letters
New thiazole-biaryls as small molecule immunomodulators (SMIs) targeting PD-1/PD-L1 axis.
  • 1 Sep 2026
  • Bioorganic & medicinal chemistry letters
Synthesis and preliminary enzymatic evaluation of polyol-based 4-phenylbutyrate derivatives.
  • 1 Sep 2026
  • Bioorganic & medicinal chemistry letters
Biological evaluation of guanidines, bisguanidines, and their derivatives as anti-Trypanosoma cruzi agents.
  • 1 Sep 2026
  • Bioorganic & medicinal chemistry letters

FAQs on Bioorganic and Medicinal Chemistry Letters